Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03136627
What this trial is testing

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 28
Not applicableStudy completedNCT04873180
What this trial is testing

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06577961
What this trial is testing

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

Who this might be right for
Kidney CancerRCCRenal Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 37
Testing effectiveness (Phase 2)UnknownNCT00039169
What this trial is testing

BAY 59-8862 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Theradex
Testing effectiveness (Phase 2)Study completedNCT00003105
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Memorial Sloan Kettering Cancer Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03793166
What this trial is testing

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+6 more
National Cancer Institute (NCI) 1,175
Testing effectiveness (Phase 2)Study completedNCT00045279
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT02651246
What this trial is testing

Optional Sub-study to Intraoperative Imaging With ICG Registry

Who this might be right for
Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) CancerCancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma CancerCancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer
Abramson Cancer Center at Penn Medicine 291
Large-scale testing (Phase 3)Study completedNCT00492986
What this trial is testing

An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 1,150
Not applicableActive Not RecruitingNCT04120805
What this trial is testing

Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy

Who this might be right for
Kidney Cancer
University of Chicago 178
Early research (Phase 1)Study completedNCT00418366
What this trial is testing

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Who this might be right for
Renal InsufficiencyHemodialysis
Merck Sharp & Dohme LLC 24
Not applicableNot Yet RecruitingNCT07124403
What this trial is testing

DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure

Who this might be right for
Renal ImpairmentDigestive CancersBreast Cancer
Centre Hospitalier Universitaire de Besancon 742
Not applicableStudy completedNCT06056505
What this trial is testing

Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy

Who this might be right for
Kidney Tumor
University of Leipzig 370
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Testing effectiveness (Phase 2)Study completedNCT01689662
What this trial is testing

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Endocyte 40
Not applicableStudy completedNCT06345183
What this trial is testing

Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Bristol-Myers Squibb 327
Not applicableStudy completedNCT04168788
What this trial is testing

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

Who this might be right for
Hepatic Veno-Occlusive DiseaseNephroblastomaAcute Lymphoblastic Leukemia
University Hospital, Angers 85
Testing effectiveness (Phase 2)Ended earlyNCT00790842
What this trial is testing

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
PrECOG, LLC. 63
Testing effectiveness (Phase 2)Study completedNCT00083941
What this trial is testing

TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Oxford BioMedica 25
Next Page